We recently generated and characterized a fusion protein consisting of the TLR5-ligand flagellin and the major birch pollen allergen Bet v 1 (rFlaA:Betv1) [3], which was meanwhile shown to suppress TH2 responses in vitro and allergic sensitization in vivo [3]. Here, TLR5 is linked to hypersensitivity reaction disease.